Oncogenic role of microRNA‑20a in human uveal melanoma

Zhou,Jinzi; Jiang,Jian; Wang,Shuhong; Xia,Xiaobo

doi:10.3892/mmr.2016.5433

Oncogenic role of microRNA‑20a in human uveal melanoma

Authors:
- Jinzi Zhou
- Jian Jiang
- Shuhong Wang
- Xiaobo Xia
View Affiliations

Affiliations: Department of Ophthalmology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300, P.R. China, Department of Ophthalmology, Xiangya Hospital Central South University, Changsha, Hunan 410008, P.R. China
Published online on: June 23, 2016 https://doi.org/10.3892/mmr.2016.5433
Pages: 1560-1566
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

As a member of the microRNA (miR)-17-92 cluster, miR‑20a has been indicated to be involved in the regulation of the proliferation and invasion of various cancer cells. Previous studies have observed elevated plasma levels of miR‑20a in patients with uveal melanoma (UM), compared with normal controls. In the present study, the potential function of miR‑20a in UM was investigated. Reverse transcription‑quantitative polymerase chain reaction analysis was performed to detect the expression levels of miR‑20a in UM cells and tissues. The functions of miR‑20a on cell proliferation, migration and invasion were determined in vitro using 3‑(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide and Transwell assays, respectively. The expression levels of miR‑20a were significantly increased in the UM cells and tissues (P<0.05). Subsequently, miR‑20a mimics were transfected into UM cells, which led to increases in cell growth, migration and invasion activities. By contrast, miR‑20a inhibition markedly suppressed the viability and motility of UM cells in vitro. These data provided convincing evidence that miR‑20a may function as an oncogenic miRNA, and may be involved in promoting cell growth and motility in the molecular etiology of UM, suggesting its potential as a candidate therapeutic target for the treatment of patients with UM.

View Figures

View References

1	Field MG and Harbour JW: Recent developments in prognostic and predictive testing in uveal melanoma. Curr Opin Ophthalmol. 25:234–239. 2014. View Article : Google Scholar : PubMed/NCBI
2	Schoenfield L: Uveal melanoma: A pathologist's perspective and review of translational developments. Adv Anat Pathol. 21:138–143. 2014. View Article : Google Scholar : PubMed/NCBI
3	Eschelman DJ, Gonsalves CF and Sato T: Transhepatic therapies for metastatic uveal melanoma. Semin Intervent Radiol. 30:39–48. 2013. View Article : Google Scholar :
4	Rashid AB and Grossniklaus HE: Clinical, pathologic, and imaging features and biological markers of uveal melanoma. Methods Mol Biol. 1102:397–425. 2014. View Article : Google Scholar
5	Werdich XQ, Jakobiec FA, Singh AD and Kim IK: A review of advanced genetic testing for clinical prognostication in uveal melanoma. Semin Ophthalmol. 28:361–371. 2013. View Article : Google Scholar : PubMed/NCBI
6	Yan X, Xu H and Yan Z: Functional perspective and implications of gene expression by noncoding RNAs. Cancer Transl Med. 1:137–152. 2015. View Article : Google Scholar
7	Chen Y, Zhao H, Tan Z, Zhang C and Fu X: Bottleneck limitations for microRNA-based therapeutics from bench to the bedside. Pharmazie. 70:147–154. 2015.PubMed/NCBI
8	Mansoori B, Mohammadi A, Shirjang S and Baradaran B: Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy. Cell Mol Biol (Noisy-le-grand). 61:1–10. 2015.
9	Hata A and Lieberman J: Dysregulation of microRNA biogenesis and gene silencing in cancer. Sci Signal. 8:re32015. View Article : Google Scholar : PubMed/NCBI
10	Shen J and Hung MC: Signaling-mediated regulation of MicroRNA processing. Cancer Res. 75:783–791. 2015. View Article : Google Scholar : PubMed/NCBI
11	Dong F and Lou D: MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets. Mol Vis. 18:537–546. 2012.PubMed/NCBI
12	Liu N, Sun Q, Chen J, Li J, Zeng Y, Zhai S, Li P, Wang B and Wang X: MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-κB1 pathway. Oncol Rep. 28:961–968. 2012.PubMed/NCBI
13	Yan D, Dong XD, Chen X, Yao S, Wang L, Wang J, Wang C, Hu DN, Qu J and Tu L: Role of microRNA-182 in posterior uveal melanoma: Regulation of tumor development through MITF, BCL2 and cyclin D2. PLoS One. 7:e409672012. View Article : Google Scholar : PubMed/NCBI
14	Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, et al: Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 132:875–886. 2008. View Article : Google Scholar : PubMed/NCBI
15	Wang Z, Wang B, Shi Y, Xu C, Xiao HL, Ma LN, Xu SL, Yang L, Wang QL, Dang WQ, et al: Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2. Oncogene. 34:1407–1419. 2015. View Article : Google Scholar
16	Xiong Y, Zhang L and Kebebew E: MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1. PLoS One. 9:e961032014. View Article : Google Scholar : PubMed/NCBI
17	Li X, Zhang Z, Yu M, Li L, Du G, Xiao W and Yang H: Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2). Int J Mol Sci. 14:16226–16239. 2013. View Article : Google Scholar : PubMed/NCBI
18	Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436. 2008. View Article : Google Scholar : PubMed/NCBI
19	Zhao S, Yao D, Chen J, Ding N and Ren F: MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo. PLoS One. 10:e01209052015. View Article : Google Scholar : PubMed/NCBI
20	Qiang XF, Zhang ZW, Liu Q, Sun N, Pan LL, Shen J, Li T, Yun C, Li H and Shi LH: miR-20a promotes prostate cancer invasion and migration through targeting ABL2. J Cell Biochem. 115:1269–1276. 2014. View Article : Google Scholar : PubMed/NCBI
21	Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M, Wu K, Whittle J, Ju X, Hyslop T, et al: A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol. 182:509–517. 2008. View Article : Google Scholar : PubMed/NCBI
22	Zhang Y, Zheng L, Ding Y, Li Q, Wang R, Liu T, Sun Q, Yang H, Peng S, Wang W and Chen L: MiR-20a induces cell radioresistance by activating the PTEN/PI3K/Akt signaling pathway in hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 92:1132–1140. 2015. View Article : Google Scholar : PubMed/NCBI
23	Hong TH and Park IY: MicroRNA expression profiling of diagnostic needle aspirates from surgical pancreatic cancer specimens. Ann Surg Treat Res. 87:290–297. 2014. View Article : Google Scholar : PubMed/NCBI
24	Achberger S, Aldrich W, Tubbs R, Crabb JW, Singh AD and Triozzi PL: Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease. Mol Immunol. 58:182–186. 2014. View Article : Google Scholar :
25	Puri KS, Suresh KR, Gogtay NJ and Thatte UM: Declaration of Helsinki, 2008: Implications for stakeholders in research. J Postgrad Med. 55:131–134. 2009. View Article : Google Scholar : PubMed/NCBI
26	Hsu SD, Tseng YT, Shrestha S, Lin YL, Khaleel A, Chou CH, Chu CF, Huang HY, Lin CM and Ho SY: miRTarBase update 2014: An information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 42(Database Issue): D78–D85. 2014. View Article : Google Scholar :
27	Wixon J and Kell D: The Kyoto encyclopedia of genes and genomes-KEGG. Yeast. 17:48–55. 2000.PubMed/NCBI
28	Qureshi R and Sacan A: A novel method for the normalization of microRNA RT-PCR data. BMC Med Genomics. 6(Suppl 1): S142013. View Article : Google Scholar : PubMed/NCBI
29	Li Z, Yu X, Shen J and Jiang Y: MicroRNA dysregulation in uveal melanoma: A new player enters the game. Oncotarget. 6:4562–4568. 2015. View Article : Google Scholar : PubMed/NCBI
30	Eldh M, Olofsson Bagge R, Lässer C, Svanvik J, Sjöstrand M, Mattsson J, Lindnér P, Choi DS, Gho YS and Lötvall J: MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma. BMC Cancer. 14:9622014. View Article : Google Scholar : PubMed/NCBI
31	Grillari J, Hackl M and Grillari-Voglauer R: miR-17-92 cluster: Ups and downs in cancer and aging. Biogerontology. 11:501–506. 2010. View Article : Google Scholar : PubMed/NCBI
32	Xie R, Lin X, Du T, Xu K, Shen H, Wei F, Hao W, Lin T, Lin X, Qin Y, et al: Targeted disruption of miR-17-92 impairs mouse spermatogenesis by activating mTOR signaling pathway. Medicine (Baltimore). 95:e27132016. View Article : Google Scholar
33	Li L, Shi JY, Zhu GQ and Shi B: MiR-17-92 cluster regulates cell proliferation and collagen synthesis by targeting TGFB pathway in mouse palatal mesenchymal cells. J Cell Biochem. 113:1235–1244. 2012. View Article : Google Scholar
34	Zhang GJ, Li Y, Zhou H, Xiao HX and Zhou T: miR-20a is an independent prognostic factor in colorectal cancer and is involved in cell metastasis. Mol Med Rep. 10:283–291. 2014.PubMed/NCBI
35	Zhuo W, Ge W, Meng G, Jia S, Zhou X and Liu J: MicroRNA-20a promotes the proliferation and cell cycle of human osteosarcoma cells by suppressing early growth response 2 expression. Mol Med Rep. 12:4989–4994. 2015.PubMed/NCBI
36	Wei W, Hou J, Alder O, Ye X, Lee S, Cullum R, Chu A, Zhao Y, Warner SM, Knight DA, et al: Genome-wide microRNA and messenger RNA profiling in rodent liver development implicates mir302b and mir20a in repressing transforming growth factor-beta signaling. Hepatology. 57:2491–2501. 2013. View Article : Google Scholar : PubMed/NCBI
37	Ristau J, Staffa J, Schrotz-King P, Gigic B, Makar KW, Hoffmeister M, Brenner H, Ulrich A, Schneider M, Ulrich CM and Habermann N: Suitability of circulating miRNAs as potential prognostic markers in colorectal cancer. Cancer Epidemiol Biomarkers Prev. 23:2632–2637. 2014. View Article : Google Scholar : PubMed/NCBI